Proteomics Data Anaysis Service

Quantum Chemical (DFT) & Pharmacokinetic Profiling

Investigate the electronic structure, reactivity, and quantum mechanical properties of your compounds with our rigorous DFT analysis. Dawn of Bioinformatics Ltd. combines high-level quantum chemical calculations with advanced pharmacokinetic profiling and structural modeling to deliver a complete understanding of molecular performance.
Our workflows extend from experimental data interpretation to computational refinement, including structure elucidation from GC-MS and IR spectra, 2D-to-3D structure generation, geometry optimization, and vibrational analysis. In addition, we support analogue design and modification to improve molecular properties. This integrated approach enhances predictive accuracy, reduces experimental uncertainty, and enables efficient compound analysis and optimization.

Quantum Chemical (DFT) & Pharmacokinetic Profiling

Overview

Dawn of Bioinformatics Ltd. delivers advanced Quantum Chemical and pharmacokinetic profiling solutions to investigate the electronic structure, reactivity, and physicochemical properties of molecular systems at a fundamental level. Our DawniLab experts leverage Density Functional Theory (DFT) alongside state-of-the-art computational tools to accurately model molecular behavior, optimize structures, and predict interaction potential. By integrating quantum mechanical analysis with pharmacokinetic evaluation and analogue design strategies, we provide comprehensive insights that support rational compound development and data-driven decision-making.

Key Features

• Density Functional Theory (DFT) calculations for electronic structure analysis.
• Geometry optimization and vibrational frequency analysis.
• HOMO–LUMO energy analysis and molecular orbital visualization.
• FTIR, Raman, and VCD spectral simulation and interpretation.
• Structure elucidation from GC-MS and IR spectral data.
• 2D to 3D molecular structure conversion and refinement.
• Analogue design and structural modification strategies.
• Comprehensive ADME and pharmacokinetic profiling.
• Drug-likeness and toxicity prediction.
• Powered by industry-standard tools (Gaussian, ORCA, BIOVIA Discovery Studio).

Demo & Results

We present selected case studies demonstrating the effectiveness of our integrated quantum chemical and pharmacokinetic workflows in molecular characterization and compound optimization. These examples highlight how our DFT analysis, spectral interpretation, and structural modeling approaches provide accurate insights into molecular structure, reactivity, and pharmacokinetic suitability supporting reliable compound identification, refinement, and decision-making in chemical and pharmaceutical research.